pubmed-article:12045170 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:12045170 | lifeskim:mentions | umls-concept:C0229671 | lld:lifeskim |
pubmed-article:12045170 | lifeskim:mentions | umls-concept:C2936350 | lld:lifeskim |
pubmed-article:12045170 | lifeskim:mentions | umls-concept:C0741968 | lld:lifeskim |
pubmed-article:12045170 | lifeskim:mentions | umls-concept:C0030306 | lld:lifeskim |
pubmed-article:12045170 | lifeskim:mentions | umls-concept:C0441655 | lld:lifeskim |
pubmed-article:12045170 | lifeskim:mentions | umls-concept:C2745955 | lld:lifeskim |
pubmed-article:12045170 | lifeskim:mentions | umls-concept:C1414478 | lld:lifeskim |
pubmed-article:12045170 | lifeskim:mentions | umls-concept:C0255874 | lld:lifeskim |
pubmed-article:12045170 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
pubmed-article:12045170 | lifeskim:mentions | umls-concept:C0596481 | lld:lifeskim |
pubmed-article:12045170 | pubmed:issue | 22 | lld:pubmed |
pubmed-article:12045170 | pubmed:dateCreated | 2002-6-4 | lld:pubmed |
pubmed-article:12045170 | pubmed:abstractText | In the last decades, interest has increased in the potential deleterious atherogenic effects of some cellular elastase activities. The results of experimental and clinical investigations were inconsistent. In this report, we assessed the associations of serum elastase activity and serum elastase inhibitors with carotid plaque occurrence during the 4-year follow-up in a population of 859 subjects free of coronary heart disease and stroke (age, 59 to 71 years). | lld:pubmed |
pubmed-article:12045170 | pubmed:language | eng | lld:pubmed |
pubmed-article:12045170 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12045170 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:12045170 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12045170 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12045170 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:12045170 | pubmed:month | Jun | lld:pubmed |
pubmed-article:12045170 | pubmed:issn | 1524-4539 | lld:pubmed |
pubmed-article:12045170 | pubmed:author | pubmed-author:ZureikMahmoud... | lld:pubmed |
pubmed-article:12045170 | pubmed:author | pubmed-author:CourbonDomini... | lld:pubmed |
pubmed-article:12045170 | pubmed:author | pubmed-author:TouboulPierre... | lld:pubmed |
pubmed-article:12045170 | pubmed:author | pubmed-author:DucimetièrePi... | lld:pubmed |
pubmed-article:12045170 | pubmed:author | pubmed-author:RobertLadisla... | lld:pubmed |
pubmed-article:12045170 | pubmed:author | pubmed-author:BizbizLatifaL | lld:pubmed |
pubmed-article:12045170 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:12045170 | pubmed:day | 4 | lld:pubmed |
pubmed-article:12045170 | pubmed:volume | 105 | lld:pubmed |
pubmed-article:12045170 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:12045170 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:12045170 | pubmed:pagination | 2638-45 | lld:pubmed |
pubmed-article:12045170 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:12045170 | pubmed:meshHeading | pubmed-meshheading:12045170... | lld:pubmed |
pubmed-article:12045170 | pubmed:meshHeading | pubmed-meshheading:12045170... | lld:pubmed |
pubmed-article:12045170 | pubmed:meshHeading | pubmed-meshheading:12045170... | lld:pubmed |
pubmed-article:12045170 | pubmed:meshHeading | pubmed-meshheading:12045170... | lld:pubmed |
pubmed-article:12045170 | pubmed:meshHeading | pubmed-meshheading:12045170... | lld:pubmed |
pubmed-article:12045170 | pubmed:meshHeading | pubmed-meshheading:12045170... | lld:pubmed |
pubmed-article:12045170 | pubmed:meshHeading | pubmed-meshheading:12045170... | lld:pubmed |
pubmed-article:12045170 | pubmed:meshHeading | pubmed-meshheading:12045170... | lld:pubmed |
pubmed-article:12045170 | pubmed:meshHeading | pubmed-meshheading:12045170... | lld:pubmed |
pubmed-article:12045170 | pubmed:meshHeading | pubmed-meshheading:12045170... | lld:pubmed |
pubmed-article:12045170 | pubmed:meshHeading | pubmed-meshheading:12045170... | lld:pubmed |
pubmed-article:12045170 | pubmed:meshHeading | pubmed-meshheading:12045170... | lld:pubmed |
pubmed-article:12045170 | pubmed:meshHeading | pubmed-meshheading:12045170... | lld:pubmed |
pubmed-article:12045170 | pubmed:meshHeading | pubmed-meshheading:12045170... | lld:pubmed |
pubmed-article:12045170 | pubmed:meshHeading | pubmed-meshheading:12045170... | lld:pubmed |
pubmed-article:12045170 | pubmed:meshHeading | pubmed-meshheading:12045170... | lld:pubmed |
pubmed-article:12045170 | pubmed:meshHeading | pubmed-meshheading:12045170... | lld:pubmed |
pubmed-article:12045170 | pubmed:year | 2002 | lld:pubmed |
pubmed-article:12045170 | pubmed:articleTitle | Serum elastase activity, serum elastase inhibitors, and occurrence of carotid atherosclerotic plaques: the Etude sur le Vieillissement Artériel (EVA) study. | lld:pubmed |
pubmed-article:12045170 | pubmed:affiliation | National Institute of Health and Medical Research (INSERM), Unit 258, Villejuif, France. zureik@vjf.inserm.fr | lld:pubmed |
pubmed-article:12045170 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:12045170 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12045170 | lld:pubmed |